XML 44 R33.htm IDEA: XBRL DOCUMENT v3.25.3
Significant Contracts and Concentrations - Qurate Agreements (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Product Information [Line Items]          
Net revenue $ 1,118 $ 1,912 $ 3,771 $ 7,050  
Accounts receivable 1,403   1,403   $ 2,269
Net licensing revenue          
Product Information [Line Items]          
Net revenue $ 1,118 $ 1,505 $ 3,771 $ 6,515  
Sales | Customer concentration risk | Qurate          
Product Information [Line Items]          
Concentration risk, percentage 21.00% 14.00% 22.00% 46.00%  
Sales | Customer concentration risk | Qurate | Net licensing revenue          
Product Information [Line Items]          
Net revenue $ 240 $ 260 $ 810 $ 3,270  
Accounts receivable | Customer concentration risk | Qurate          
Product Information [Line Items]          
Accounts receivable $ 250   $ 250   $ 400
Concentration risk, percentage     18.00%   18.00%